SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 74 filers reported holding SAGE THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,813,283 | -29.1% | 88,109 | +61.9% | 0.00% | 0.0% |
| Q2 2023 | $2,559,252 | +19.0% | 54,429 | +6.2% | 0.00% | 0.0% |
| Q1 2023 | $2,149,821 | +479.7% | 51,235 | +426.9% | 0.00% | – |
| Q4 2022 | $370,836 | -23.5% | 9,723 | -21.5% | 0.00% | – |
| Q3 2022 | $485,000 | +484.3% | 12,387 | +381.6% | 0.00% | – |
| Q2 2022 | $83,000 | +59.6% | 2,572 | +65.7% | 0.00% | – |
| Q1 2022 | $52,000 | -1.9% | 1,552 | +24.6% | 0.00% | – |
| Q4 2021 | $53,000 | -98.4% | 1,246 | -98.3% | 0.00% | -100.0% |
| Q3 2021 | $3,294,000 | -53.4% | 74,343 | -40.2% | 0.00% | -50.0% |
| Q2 2021 | $7,063,000 | -9.5% | 124,336 | +19.2% | 0.00% | 0.0% |
| Q1 2021 | $7,808,000 | -14.6% | 104,316 | -1.4% | 0.00% | 0.0% |
| Q4 2020 | $9,148,000 | -2.9% | 105,757 | -68.3% | 0.00% | 0.0% |
| Q3 2020 | $9,420,000 | +62.8% | 334,065 | +33.9% | 0.00% | 0.0% |
| Q2 2020 | $5,788,000 | +74.5% | 249,476 | +116.1% | 0.00% | +100.0% |
| Q1 2020 | $3,316,000 | -41.9% | 115,462 | +38.4% | 0.00% | -50.0% |
| Q4 2019 | $5,705,000 | -90.8% | 83,450 | -81.0% | 0.00% | -88.2% |
| Q3 2019 | $61,726,000 | -14.1% | 439,990 | +10.4% | 0.02% | -19.0% |
| Q2 2019 | $71,842,000 | +21.6% | 398,460 | +7.3% | 0.02% | +16.7% |
| Q1 2019 | $59,057,000 | +98.2% | 371,305 | +19.4% | 0.02% | +80.0% |
| Q4 2018 | $29,800,000 | -45.7% | 311,101 | -20.0% | 0.01% | -37.5% |
| Q3 2018 | $54,905,000 | +25.5% | 388,706 | +39.1% | 0.02% | +23.1% |
| Q2 2018 | $43,743,000 | +62.8% | 279,456 | +58.9% | 0.01% | +62.5% |
| Q1 2018 | $26,870,000 | +422.5% | 175,894 | +463.3% | 0.01% | +700.0% |
| Q4 2017 | $5,143,000 | -20.6% | 31,225 | -70.0% | 0.00% | -50.0% |
| Q3 2017 | $6,480,000 | +8.9% | 104,016 | +39.2% | 0.00% | 0.0% |
| Q2 2017 | $5,951,000 | +149.4% | 74,723 | +122.6% | 0.00% | +100.0% |
| Q1 2017 | $2,386,000 | +24.7% | 33,575 | -10.4% | 0.00% | 0.0% |
| Q4 2016 | $1,913,000 | +94.8% | 37,464 | +75.6% | 0.00% | – |
| Q3 2016 | $982,000 | +19.5% | 21,339 | -21.7% | 0.00% | – |
| Q2 2016 | $822,000 | +1.0% | 27,266 | +7.4% | 0.00% | – |
| Q1 2016 | $814,000 | -43.7% | 25,392 | +2.4% | 0.00% | -100.0% |
| Q4 2015 | $1,446,000 | +123.8% | 24,804 | +62.6% | 0.00% | – |
| Q3 2015 | $646,000 | -37.6% | 15,256 | +7.6% | 0.00% | – |
| Q2 2015 | $1,035,000 | +531.1% | 14,177 | +335.1% | 0.00% | – |
| Q1 2015 | $164,000 | +1540.0% | 3,258 | +1120.2% | 0.00% | – |
| Q4 2014 | $10,000 | – | 267 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
| Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
| Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
| DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
| Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
| Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
| Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
| Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
| Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
| SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |